All About MS Header Photos

New approach to MS research

Posted on October 12th, 2005

New approach to multiple sclerosis research hopes to find more effective treatments, cure
12 Oct 2005  

A new university-public research partnership will help physicians and researchers work toward a better understanding of multiple sclerosis (MS), the development of novel treatments and ultimately the goal of finding a cure. The Oak Clinic/Kent State University Consortium for Multiple Sclerosis and Neurodegenerative Disease Research combines the clinical expertise of physicians dedicated to the diagnosis and

read more »

Categories: Main Page

Copaxone – long term use safe

Posted on October 03rd, 2005

Long-term Use of Glatiramer Acetate (Copaxone) for Multiple Sclerosis Appears Safe and Efficacious: Presented at ECTRIMS By Bruce Sylvester THESSALONIKI, GREECE – September 30, 2005 – Patients with relapsing-remitting multiple sclerosis who used glatiramer acetate (Copaxone) for up to 26 years show sustained efficacy and safety of treatment, researchers reported here. “These were patients in the ‘compassionate use’ program for this drug before any multiple sclerosis drugs were approved,” said… read more »

Categories: Main Page

efficacy of glatiramer acetate in beta-interferon-intolerant MS patients

Posted on October 01st, 2005

The efficacy of glatiramer acetate in beta-interferon-intolerant MS patients.
Objectives – Glatiramer acetate (GA) is routinely used in multiple sclerosis (MS) patients who cannot tolerate or fail to respond to beta-interferon (IFN-beta). The aim of this study was to assess the efficacy and tolerability of GA in these patients. Methods – Fifteen relapsing-remitting MS patients who had discontinued IFN-beta therapy due to side effects were included in this open, 1-year prospective… read more »

Categories: Main Page